COMPANY PROFILE

ZSPepLib

Explore full profile

ZSPepLib is a polypeptide drug developer

ChinaFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2019

Total funding $10–50M Disclosed equity funding

At a glance

Status: Operational
Founded: 2017
Headquarters: China
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based

Founder mafia, market maps, research and news connected to this company by Dealroom

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jul 2019	$15M	$58M	Undisclosed	—

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MIMetrodora InstituteA medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders	Salt Lake City, United States	Operational	39	$35M	$140M
DEDevelogenA biology-driven drug discovery company developing novel therapies for diabetes and obesity	Göttingen, Germany	Acquired
VBVero BiotechAn emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions	Atlanta, United States	Operational
SYSydnexisBiotech & Life Sciences	Del Mar, United States	Operational
CHCabinet HealthA sustainable healthcare company, starting with over-the-counter medicine	New York City, United States	Operational
GAGalenicumProduction and distribution of pharmaceutical goods in various formats	Esplugues de Llobregat, Spain	Operational
XBXeno BiosciencesXeno Biosciences, Inc operates as a biopharmaceutical company	Somerville, United States	Operational
HPHerantis PharmaInnovative biotech company developing disease modifying therapies for Parkinson’s disease	Helsinki, Finland	Operational